Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
Ritthideach Yorsaeng, Nungruthai Suntronwong, Harit Phowatthanasathian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10

Showing 10 citing articles:

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 86-86
Open Access | Times Cited: 85
Heterologous prime–boost strategies for COVID-19 vaccines
Binaya Sapkota, Bhuvan Saud, Ranish Shrestha, et al.
Journal of Travel Medicine (2021)
Open Access | Times Cited: 85
COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
Ying Liu, Junyan Han, Xin Li, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1458-1458
Open Access | Times Cited: 62
The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant
Alexandra B. Hogan, Sean L. Wu, Patrick Doohan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 23
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccines in healthy adults
Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac
Chris Ka Pun Mok, Samuel M. S. Cheng, Chunke Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Immune responses to SARS-CoV-2 infection and COVID-19 vaccines
Basista Rabina Sharma, Ravindra P. Veeranna
Exploration of Immunology (2022) Vol. 2, Iss. 5, pp. 648-664
Open Access | Times Cited: 2
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Criteria for judging the immune markers of COVID‐19 disease vaccines
Nan Lin, H.-S. Fu, Dan Pu, et al.
MedComm (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 1
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
Sira Nanthapisal, Thanyawee Puthanakit, Peera Jaru-Ampornpan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top